Skip to main content

Table 2 Subgroup analysis of the prevalence of EBV infection in gastric cancer patients

From: Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis

Characteristics

Categories

No. of Studies

Pooled prevalence (%) (95% CI)

Heterogeneity test

I2%, p-value

Differences between subgroups; χ2 test

(p-value)

Overall

–

71

8.77 (7.73–9.92)

83.2%, P < 0.01

–

Study design

Cross-sectional

41

8.22 (6.90–9.77)

88.2%, P < 0.01

P = 0.15

Case-control

30

9.71 (8.32–11.30)

59.4%, P < 0.01

Publication date

≤2005

42

8.91 (7.65–10.35)

82.5%, P < 0.01

P = 0.77

> 2005

29

8.56 (6.81–10.71)

84.6%, P < 0.01

Sex

Male

46

10.83 (9.43–12.40)

73.2%, P < 0.01

P < 0.0001†

Female

46

5.72 (4.27–7.64)

74.9%, P < 0.01

Study location

Africa

4

11.93 (5.97–22.44)

76.8%, P < 0.01

P = 0.64

America

16

9.51 (7.45–12.07)

76.8%, P < 0.01

Asia

35

8.38 (7.15–9.80)

84.1%, P < 0.01

Europe

17

8.21 (5.82–11.46)

80.4%, P < 0.01

Development status

Developed countries

34

8.42 (7.11–9.94)

82.1%, P < 0.01

P = 0.64

Developing countries

39

8.92 (7.40–10.73)

83.5%, P < 0.01

Sample type

FFPE

69

8.49 (7.54–9.55)

79.9%, P < 0.01

P < 0.0001†

Biopsy

2

20.36 (16.89–24.32)

0%, P = 0.9

Lauren’s histological type

Intestinal type

40

8.10 (6.64–9.83)

69.2%, P < 0.01

P = 0.31

Diffuse type

40

9.41 (7.54–11.69)

77.0%, P < 0.01

Tumor anatomical location

Cardia

32

12.47 (10.39–14.89)

24.8%, P = 0.1

P = 0.0002†

Body

32

11.68 (9.96–13.65)

32.0%, P = 0.04

Antrum

35

6.29 (4.67–8.42)

76.8%, P < 0.01

Depth of invasion

Early

7

13.00 (9.20–18.06)

0%, P = 0.71

P = 0.45

Advanced

7

10.80 (7.64–15.06)

58.1%, P = 0.03

Tumor stage

I + II

14

7.39 (5.79–9.39)

29.5%, P = 0.14

P = 0.36

III + IV

14

8.80 (6.57–11.68)

64.4%, P < 0.01

Lymph node invasion

Absent

14

8.75 (6.02–12.55)

57.9%, P < 0.01

P = 0.91

Present

14

9.00 (6.33–12.65)

77.4%, P < 0.01

  1. FFPE Formalin-Fixed Paraffin-Embedded
  2. †Statistically significant